Biomarin Pharmaceutical (bmrn 1.25 05/15/27)

13F holders, Q1 2026 (March 31)
14holders −2
2new positions
4sold out
$0.96avg. 13F price*

At the end of Q1 2026, 14 institutions reported holding Biomarin Pharmaceutical (bmrn 1.25 05/15/27) in their 13F filings, down 2 from Q4 2025. 2 opened new positions and 4 sold out. The largest holders were Focus Partners Wealth ($3.2M), State of Wisconsin Investment Board ($2.9M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.8M).

Company
Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
CUSIP
09061GAK7
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 15Q1 2024Q2 2024: 18Q2 2024Q3 2024: 20Q3 2024Q4 2024: 20Q4 2024Q1 2025: 16Q1 2025Q2 2025: 17Q2 2025Q3 2025: 15Q3 2025Q4 2025: 16Q4 2025Q1 2026: 14Q1 2026Q2 2026: 12Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$1.6M
Exits4$993K

All 13F filers, Q4 2025 → Q1 2026: 1,611,000 shares bought and 660,460 shares sold, net +950,540 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 14 holders

Focus Partners Wealth 0.00% Reduce -2.2% 3,348,000 $3.2M
State of Wisconsin Investment Board 0.01% No change 3,000,000 $2.9M
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.00% No change 2,900,000 $2.8M
Janus Henderson Group PLC 0.00% New 1,600,000 $1.5M
Sei Investments Co. 0.00% No change 371,000 $357K
Oppenheimer Asset Management Inc. 0.00% Reduce -3.3% 176,000 $170K
Stephens Inc. 0.00% No change 54,000 $52K
MML Investors Services, LLC 0.00% No change 49,000 $47K
Mariner, LLC 0.00% No change 42,000 $40K
&partners 0.00% No change 18,000 $17K
HB Wealth Management, LLC 0.00% New 11,000 $11K
DAVENPORT & Co LLC 0.00% No change 10,000 $10K
Cetera Investment Advisers 0.00% No change 10,000 $10K
Oddo BHF Asset Management Sas 0.00% No change 225 $218

"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 1.25 05/15/27)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 1.25 05/15/27) the manager owns.